Cargando…

The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports

Placenta-derived amniotic cells have prominent features for application in regenerative medicine. However, there are still discrepancies in the characterization of human amniotic epithelial and mesenchymal stromal cells. It seems crucial that the characterization of human amniotic membrane cells be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghamari, Seyyed-Hadi, Abbasi-Kangevari, Mohsen, Tayebi, Tahereh, Bahrami, Soheyl, Niknejad, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083014/
https://www.ncbi.nlm.nih.gov/pubmed/32232037
http://dx.doi.org/10.3389/fbioe.2020.00180
_version_ 1783508457240920064
author Ghamari, Seyyed-Hadi
Abbasi-Kangevari, Mohsen
Tayebi, Tahereh
Bahrami, Soheyl
Niknejad, Hassan
author_facet Ghamari, Seyyed-Hadi
Abbasi-Kangevari, Mohsen
Tayebi, Tahereh
Bahrami, Soheyl
Niknejad, Hassan
author_sort Ghamari, Seyyed-Hadi
collection PubMed
description Placenta-derived amniotic cells have prominent features for application in regenerative medicine. However, there are still discrepancies in the characterization of human amniotic epithelial and mesenchymal stromal cells. It seems crucial that the characterization of human amniotic membrane cells be investigated to determine whether there are currently discrepancies in their characterization reports. In addition, possible causes for the witnessed discrepancies need to be addressed toward paving the way for further clinical application and safer practices. The objective of this review is to investigate the marker characterization as well as the potential causes of the discrepancies in the previous reports on placenta-derived amniotic epithelial and mesenchymal stromal cells. The current discrepancies could be potentially due to reasons including passage number and epithelial to mesenchymal transition (EMT), cell heterogeneity, isolation protocols and cross-contamination, the region of cell isolation on placental disk, measuring methods, and gestational age.
format Online
Article
Text
id pubmed-7083014
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70830142020-03-30 The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports Ghamari, Seyyed-Hadi Abbasi-Kangevari, Mohsen Tayebi, Tahereh Bahrami, Soheyl Niknejad, Hassan Front Bioeng Biotechnol Bioengineering and Biotechnology Placenta-derived amniotic cells have prominent features for application in regenerative medicine. However, there are still discrepancies in the characterization of human amniotic epithelial and mesenchymal stromal cells. It seems crucial that the characterization of human amniotic membrane cells be investigated to determine whether there are currently discrepancies in their characterization reports. In addition, possible causes for the witnessed discrepancies need to be addressed toward paving the way for further clinical application and safer practices. The objective of this review is to investigate the marker characterization as well as the potential causes of the discrepancies in the previous reports on placenta-derived amniotic epithelial and mesenchymal stromal cells. The current discrepancies could be potentially due to reasons including passage number and epithelial to mesenchymal transition (EMT), cell heterogeneity, isolation protocols and cross-contamination, the region of cell isolation on placental disk, measuring methods, and gestational age. Frontiers Media S.A. 2020-03-13 /pmc/articles/PMC7083014/ /pubmed/32232037 http://dx.doi.org/10.3389/fbioe.2020.00180 Text en Copyright © 2020 Ghamari, Abbasi-Kangevari, Tayebi, Bahrami and Niknejad. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Ghamari, Seyyed-Hadi
Abbasi-Kangevari, Mohsen
Tayebi, Tahereh
Bahrami, Soheyl
Niknejad, Hassan
The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports
title The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports
title_full The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports
title_fullStr The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports
title_full_unstemmed The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports
title_short The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports
title_sort bottlenecks in translating placenta-derived amniotic epithelial and mesenchymal stromal cells into the clinic: current discrepancies in marker reports
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083014/
https://www.ncbi.nlm.nih.gov/pubmed/32232037
http://dx.doi.org/10.3389/fbioe.2020.00180
work_keys_str_mv AT ghamariseyyedhadi thebottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT abbasikangevarimohsen thebottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT tayebitahereh thebottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT bahramisoheyl thebottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT niknejadhassan thebottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT ghamariseyyedhadi bottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT abbasikangevarimohsen bottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT tayebitahereh bottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT bahramisoheyl bottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports
AT niknejadhassan bottlenecksintranslatingplacentaderivedamnioticepithelialandmesenchymalstromalcellsintothecliniccurrentdiscrepanciesinmarkerreports